Page 52 - GPD-4-3

Gene & Protein in Disease NLRP3 in SCI and CHM

of Rett syndrome oxinflammation. Redox Biol. 2020;28:101334. reduces neuronal loss and inhibits the NLRP3 inflammasome
activation in an epileptic rat model. Curr Neurovasc Res.
doi: 10.1016/j.redox.2019.101334
2018;15(3):186-192.
75. Peng L, Wen L, Shi QF, et al. Scutellarin ameliorates
pulmonary fibrosis through inhibiting NF-κB/NLRP3- doi: 10.2174/1567202615666180731100224
mediated epithelial-mesenchymal transition and 87. Ghaffari N, Mokhtari T, Adabi M, et al. Neurological
inflammation. Cell Death Dis. 2020;11(11):978. recovery and neurogenesis by curcumin sustained‐release
system cross‐linked with an acellular spinal cord scaffold
doi: 10.1038/s41419-020-03178-2
in rat spinal cord injury: Targeting NLRP3 inflammasome
76. Larner SF, Hayes RL, Wang KKW. Unfolded protein response pathway. Phytother Res. 2024;38:2669-2686.
after neurotrauma. J Neurotrauma. 2006;23(6):807-829.
doi: 10.1002/ptr.8179
doi: 10.1089/neu.2006.23.807
88. Bagherniya M, Khedmatgozar H, Fakheran O, Xu S,
77. Schröder M, Kaufman RJ. The mammalian unfolded protein Johnston TP, Sahebkar A. Medicinal plants and bioactive
response. Annu Rev Biochem. 2005;74:739-789. natural products as inhibitors of NLRP3 inflammasome.
doi: 10.1146/annurev.biochem.73.011303.074134 Phytother Res. 2021;35(9):4804-4833.
78. Shin S, Argon Y. Stressed-Out endoplasmic reticulum doi: 10.1002/ptr.7118
inflames the mitochondria. Immunity. 2015;43(3):409-411. 89. Yin H, Guo Q, Li X, et al. Curcumin suppresses IL-1β secretion
and prevents inflammation through inhibition of the NLRP3
doi: 10.1016/j.immuni.2015.08.027
inflammasome. J Immunol. 2018;200(8):2835-2846.
79. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-
interacting protein links oxidative stress to inflammasome doi: 10.4049/jimmunol.1701495
activation. Nat Immunol. 2010;11(2):136-140. 90. Yarahmadi A, Malek F, Poorhassan M, et al. Curcumin
doi: 10.1038/ni.1831 attenuates development of depressive-like behavior in
male rats after spinal cord injury: Involvement of NLRP3
80. Matsuyama D, Watanabe M, Suyama K, Kuroiwa M, inflammasome. J Contemp Med Sci. 2022;8(3):176-183.
Mochida J. Endoplasmic reticulum stress response in the rat
contusive spinal cord injury model-susceptibility in specific 91. Kaşıkcı MB, Bağdatlıoğlu NJ. Bioavailability of Quercetin. In:
cell types. Spinal Cord. 2014;52(1):9-16. Nutrition in Conference; 2016. p. 146-151.
92. Li Y, Yao J, Han C, et al. Quercetin, inflammation and
doi: 10.1038/sc.2013.118
immunity. Nutrients. 2016;8(3):167.
81. Leal-Filho MB. Spinal cord injury: From inflammation to doi: 10.3390/nu8030167
glial scar. Surg Neurol Int. 2011;2:112.
93. Li W, Wang Y, Tang Y, et al. Quercetin alleviates osteoarthritis
doi: 10.4103/2152-7806.83732
progression in rats by suppressing inflammation and
82. Coulter ID. Evidence based complementary and alternative apoptosis via inhibition of IRAK1/NLRP3 signaling.
medicine: Promises and problems. Forsch Komplementmed. J Inflamm Res. 2021:3393-3403.
2007;14(2):102-108.
doi: 10.2147/JIR.S311924
doi: 10.1159/000101054
94. Wang X, Fu Y, Botchway BO, et al. Quercetin can improve
83. Lee WH, Loo CY, Bebawy M, Luk F, Mason RS, spinal cord injury by regulating the mTOR signaling
Rohanizadeh R. Curcumin and its derivatives: Their pathway. Front Neurol. 2022;13:905640.
application in neuropharmacology and neuroscience in the
21 century. Curr Neuropharmacol. 2013;11(4):338-378. doi: 10.3389/fneur.2022.905640
st
95. Ebrahimi B, Mokhtari T, Ghaffari N, Adabi M,
doi: 10.2174/1570159X11311040002
Hassanzadeh G. Acellular spinal cord scaffold containing
84. Ahsan R, Arshad M, Khushtar M, et al. A comprehensive quercetin-encapsulated nanoparticles plays an anti-
review on physiological effects of curcumin. Drug Res inflammatory role in functional recovery from spinal cord
(Stuttg). 2020;70(10):441-447. injury in rats. Inflammopharmacology. 2024;32:2505-2524.
doi: 10.1055/a-1207-9469 doi: 10.1007/s10787-024-01478-z
85. Tsutsui H, Cai X, Hayashi S. Interleukini X, 96. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: The
Hayashi S. physiological effectss. Mediators Inflamm. in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493-506.
2015;2015(1):630265.
doi: 10.1038/nrd2060
doi: 10.1155/2015/630265
97. Kulkarni SS, Cantó C. The molecular targets of resveratrol.
86. He Q, Jiang L, Man S, Wu L, Hu Y, Chen W. Curcumin Biochim Biophys Acta. 2015;1852(6):1114-1123.

Volume 4 Issue 3 (2025) 10 doi: 10.36922/gpd.4827